ASMB 2023: Tissue, Matrix, and Pathobiology
ASMB 2023: Tissue, Matrix, and Pathobiology
批准号:
10752769
负责人:
AMBRA POZZI
金额:
$5.5万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-07-06 至 2024-06-30
关键词:
AgeAgingAmericanAreaAwardBasic ScienceBiochemistryBiologyBiomedical EngineeringBone DevelopmentCareer ChoiceCellular biologyCitiesClinical ResearchCollaborationsCommunicationCommunitiesConnective TissueDataDietDiseaseEnsureEquipmentExtracellular MatrixFacultyFeedbackFosteringFunctional disorderFundingFunding MechanismsGenetic DiseasesGoalsHealthHomeostasisHumanImageInflammatory ResponseInjury to KidneyInvestigationJointsKnowledgeLeadershipMediatingMentorsMissionMolecularMorphogenesisNatural regenerationOrganOrganoidsPathologyPersonsPostdoctoral FellowProcessProteinsResearchResearch PersonnelResourcesRoleScienceScientistSeminalSignal TransductionSocietiesSodium ChlorideTechnologyTherapeutic InterventionThinkingTissuesTrainingTranslatingTranslational ResearchTravelUnderrepresented MinorityUnderrepresented PopulationsUnited States National Institutes of HealthUtahVisualWomanWorkcardiovascular injurycareercareer developmentcartilage developmentcostdesigndiversity and inclusionexperiencegraduate studenthost neoplasm interactionhuman diseaseimprovedinterestknowledge translationmeetingsmemberminority traineemultidisciplinarymusculoskeletal injurynext generationnovel therapeutic interventionposterspre-doctoralprogramsreceptorrepairedscaffoldsexsuccesssymposiumtooltumor
中文摘要
我们请求部分支持第11届美国基质生物学学会(ASMB)两年一度的会议,该会议题为
组织、基质和病理生物学这次面对面的会议将于2023年10月22日至25日在盐湖城举行,
犹他州。这是三个主要学会之间新的多学科和协作的联合会议:ASMB、
美国研究病理学学会和组织化学学会。它将具有尖端的基本功能,
与反映细胞/组织正常生物学的各种主题相关的临床和转译研究,以及
推动疾病进程的分子和细胞变化。本次会议将有一个共同的主旨
演讲人和三个协会所有成员感兴趣的三次共同全体会议。重要的是,
会议将有一个ASMB量身定做的计划,重点是促进基质生物学领域,以便
传播有关细胞外基质(ECM)的知识,并将这些知识转化为改善人类
健康和衰老,以及更好地治疗人类疾病。此R13应用程序的目标是:
目标1:传播和整合有关细胞外基质及其受体在健康、疾病、衰老和
再生。ASMB 2023计划反映了基质生物学科学界的不同兴趣。
它扩展和进化了对基质生物学感兴趣的领域,例如肿瘤/间质微环境;衰老-
涉及ECM变化的相关疾病;性别和饮食在ECM变化和疾病中的作用;心血管
和肌肉骨骼损伤和再生;骨和软骨发育、疾病和再生;工具
研究ECM信号;以及治疗干预和健康和疾病中ECM成像的技术。
目标2:促进培养下一代科学家,促进初级调查人员的职业生涯
在ECM领域。ASMB 2023邀请初级教员在全体会议和兼职会议上发言。
每一次会议将从初级教师和/或高级博士后和讲座中选出一名共同主席。
从提交的摘要中挑选,给实习生和初级教员介绍他们的工作的机会。ASMB
2023年还将为博士后提供组织和主持特别兴趣会议的机会。职业指导
早餐和互动海报会议也将有助于职业发展。ASMB初级调查员
奖项、创始人奖和Iozzo实习生奖将突出初级科学家。将提供旅游大奖
敬有竞争力的实习生。目标3:通过促进妇女和以下群体的职业生涯,加强多样性和包容性
代表少数族裔(URM)。ASMB 2023将在3次全体会议上展示5名妇女(9名发言者)的工作
会议;在3个嘉宾座谈会中,4名妇女和1名URM(9名发言者);#年,8名妇女和2名URM(16名发言者)
16个并发会话。在总共39位受邀发言者中,有17位是女性(43%)。一份专门的辅导早餐
还将举行专门针对妇女的职业发展问题的会议。在发言者的选择上,我们将重点放在
包括来自不同背景的人。此外,ASMB还为城市轨道交通学员保留了旅行奖励。
总体而言,这次会议将一如既往地成为ECM研究领域的开创性会议。
英文摘要
We request partial support for the 11th Biennial American Society for Matrix Biology (ASMB) conference entitled
“Tissue, Matrix, and Pathobiology”. This in-person meeting will take place October 22-25, 2023 in Salt Lake City,
Utah. This is a new multidisciplinary and collaborative joint meeting among three major societies: ASMB, the
American Society for Investigative Pathology, and The Histochemical Society. It will feature cutting edge basic,
clinical, and translational research related to a variety of topics that reflect normal biology of cells/tissues, and
the molecular and cellular alterations that drive disease processes. This meeting will have a common keynote
speaker and 3 common Plenary Sessions of interest for all members of the three societies. Importantly, the
meeting will have an ASMB tailored program focused on promoting the field of matrix biology in order to
disseminate knowledge about the extracellular matrix (ECM) and to translate this knowledge to improve human
health and aging and to better treat human disease. The Aims of this R13 application are:
Aim 1: To disseminate and integrate new knowledge about ECM and its receptors in health, disease, aging, and
regeneration. The ASMB 2023 program reflects the diverse interests of the matrix biology scientific community.
It expands and evolves areas of interest for matrix biology, such as the tumor/stroma microenvironment; aging-
related diseases involving ECM changes; the role of sex and diet in ECM changes and disease; cardiovascular
and musculoskeletal injury and regeneration; bone and cartilage development, disease, and regeneration; tools
to study ECM signaling; and technologies for therapeutic intervention and for imaging ECM in health and disease.
Aim 2: To contribute to training the next generation of scientists, and to foster the careers of junior investigators
in the area of ECM. ASMB 2023 has invited junior faculty to speak in both Plenary and Concurrent Sessions.
Each Concurrent Session will have a co-chair chosen from junior faculty and/or senior postdocs and talks
selected from submitted abstracts, giving trainees and junior faculty opportunities to present their work. ASMB
2023 will also offer postdocs the opportunity to organize and chair special interest sessions. Career mentoring
breakfasts and interactive poster sessions will also support career development. ASMB’s Junior Investigator
Award, Founders’ Award, and Iozzo Trainee Awards will highlight junior scientists. Travel Awards will be provided
to competitive trainees. Aim 3: To enhance diversity and inclusion by promoting the career of women and under-
represented minorities (URM). ASMB 2023 will showcase the work of 5 women (of 9 speakers) in 3 Plenary
Sessions; 4 women and 1 URM (of 9 speakers) in 3 Guest Symposia; 8 women and 2 URM (of 16 speakers) in
16 Concurrent Sessions. Of a total of 39 invited speakers, 17 are women (43%). A mentoring breakfast devoted
to career development issues particular to women will also be held. In the selection of speakers, we have focused
on including those from diverse backgrounds. In addition, ASMB has reserved travel awards for URM trainees.
Overall, this conference will be, as it has always been, the seminal conference in the field of ECM research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2023 Fibronectin, Integrins and Related Molecules Gordon Research Conference and Gordon Research Seminar
-
批准号:10608783
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:AMBRA POZZI
-
依托单位:
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)
-
批准号:10618237
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:AMBRA POZZI
-
依托单位:
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)
-
批准号:10451496
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:AMBRA POZZI
-
依托单位:
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis
-
批准号:8840580
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Molecular Mechanisms of Kidney Fibrosis
-
批准号:10480325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis
-
批准号:8649036
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:8803358
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:8971990
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:8442087
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:8666537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis
-
批准号:8500566
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Role of Collagen Binding Receptors in Glomerulosclerosis
-
批准号:10047698
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
Integrin/TGF-beta Axis in Tubulointerstitial Fibrosis
-
批准号:9321730
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2013
-
负责人:AMBRA POZZI
-
依托单位:
The P450 Epoxygenases as Pro-Oncogenic Enzymes
-
批准号:9248704
-
项目类别:
-
资助金额:$24.49万
-
财政年份:2012
-
负责人:AMBRA POZZI
-
依托单位:
The P450 Epoxygenases as Pro-Oncogenic Enzymes
-
批准号:8677805
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2012
-
负责人:AMBRA POZZI
-
依托单位:
The P450 Epoxygenases as Pro-Oncogenic Enzymes
-
批准号:8520263
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2012
-
负责人:AMBRA POZZI
-
依托单位:
The P450 Epoxygenases as Pro-Oncogenic Enzymes
-
批准号:8371968
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2012
-
负责人:AMBRA POZZI
-
依托单位:
THE ROLE OF INTEGRINS a1B1 and a2B2 IN COLLAGEN IV HOMEOSTASIS
-
批准号:7568445
-
项目类别:
-
资助金额:$24.59万
-
财政年份:2008
-
负责人:AMBRA POZZI
-
依托单位:
Role of Cyclooxygenase stimulated Neovascularization in Diabetic Nephropathy
-
批准号:7262465
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2005
-
负责人:AMBRA POZZI
-
依托单位:
Role of Cyclooxygenase stimulated Neovascularization in Diabetic Nephropathy
-
批准号:7471435
-
项目类别:
-
资助金额:$24.96万
-
财政年份:2005
-
负责人:AMBRA POZZI
-
依托单位:
海外基金